Category Archives: News Event

PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced financial results for the three months ended March 31, 2020. Clinical Developments and Corporate Highlights Include: Namodenoson Showed Significant Efficacy in Phase II NASH Study…

RICHARDSON, Texas–(BUSINESS WIRE)–RealPage, Inc. (NASDAQ:RP), a leading global provider of software and data analytics to the real estate industry, today announced that Steve Winn, Chairman and CEO of RealPage, will present at the Baird 2020 Virtual Global Consumer, Technology & Services Conference to be held on June 2, 2020 at 4:20 p.m. EDT. The presentation…

SEATTLE–(BUSINESS WIRE)–POSaBIT Inc. (CSE:PBIT) announces an update on the filing of its Annual Financial Statements and related Disclosures (the “Annual Disclosures”) for the year ended December 31, 2019. The Company is continuing to work diligently and expeditiously with its auditors, and anticipates that the Annual Disclosures will be filed by June 13, 2020. POSaBIT confirms…

SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today the full exercise of the underwriter’s option to purchase an additional 202,259 shares of common stock in connection with the Company’s previously announced follow-on offering that priced on May 26, 2020. In total, the Company sold 1,550,648 shares of common stock in the…

BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. today announced positive results from exploratory analyses of intracranial efficacy, including survival, in patients with HER2-positive metastatic breast cancer (MBC) who had stable or active brain metastases in the HER2CLIMB pivotal trial of TUKYSA™ (tucatinib). HER2CLIMB compared TUKYSA in combination with trastuzumab and capecitabine to trastuzumab and capecitabine alone in…

DENVER–(BUSINESS WIRE)–Schwazze, formerly operating as Medicine Man Technologies, Inc. (OTCQX:SHWZ) (“Schwazze” or “the Company”), announced today that it will be participating in two upcoming virtual investor conferences. Benzinga Virtual Cannabis Capital Conference Mr. Justin Dye, Chairman and Chief Executive Officer of Schwazze, will be discussing the Company’s recent updates during the virtual Benzinga Cannabis Capital…

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal (“BMO”) as lead arranger and agent as well…

CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco” or the “Company”) one of the largest vertically integrated multistate cannabis operators in the United States, today released its unaudited financial results for the first quarter ended March 31, 2020. All financial information presented in this release is in U.S. dollars, unless otherwise noted.…

SEATTLE–(BUSINESS WIRE)–POSaBIT Inc. (CSE:PBIT) has sold its subsidiary, DoubleBeam Inc., to FinTech company The OLB Group. POSaBIT purchased DoubleBeam in early 2018 to buttress their entry into the cannabis point of sale market, utilizing DoubleBeam’s robust hardware and software capabilities. While DoubleBeam proved to be a profitable and cutting-edge point of sale solution in the…

CALABASAS, Calif.–(BUSINESS WIRE)–Resonate Blends, Inc. (OTCQB:KOAN), a cannabis-based holding company (“Resonate” or “the Company”), announced today an update to shareholders on the filing of its Information Statement on Schedule 14C with the Securities and Exchange Commission regarding the spin-out of Textmunication, Inc. from the holding company and its execution of several key business initiatives. Dear…

MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio. Products…

WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–Abacus Health Products, Inc. (CSE: ABCS) (OTCQB: ABAHF) (“Abacus” or the “Company”) reported its financial results today for the first quarter ended March 31, 2020. All amounts are in U.S. dollars unless indicated otherwise. Update on Proposed Acquisition of Abacus by Charlotte’s Web Holdings, Inc. (“Charlotte’s Web”) Perry Antelman, CEO, stated,…